SPECIAL SUPPLEMENT ONLINE ISSUE of the CSHP House of ...€¦ · So, President-elect Daniel Dong, Treasurer Pauline Chan, and Maria Serpa who served as the parliamentarian for the

JANUARY/FEBRUARY 2018 CALIFORNIA JOURNAL OF HEALTH-SYSTEM PHARMACYVOL. 30 SUPPLEMENT 1

www.cshp.orgpartners in medication management

SPECIAL SUPPLEMENT ONLINE ISSUE 2017 ANNUAL REPORT

Report of the 42nd Annual Session of the CSHP House of Delegates

Report of the President

Report of the Treasurer

Report of the CEO

Report of the 2017 Blue Ribbon Committee on Governance

2018

SAN DIEGO

CSHP SEMINAR

October 4-7

January/February Supplement 2018 California Journal of Health-System Pharmacy cjhp 3

JANUARY/FEBRUARY 2018VOL. 30 SUPPLEMENT 1

CALIFORNIA JOURNAL OF HEALTH-SYSTEM PHARMACY

SPECIAL SUPPLEMENT ONLINE ISSUE 2017 ANNUAL REPORT

Report of the 42nd Annual Session of the CSHP House of Delegates 5Report of the President 18Report of the Treasurer 20Report of the CSHP CEO 23Report of the CSHP Blue Ribbon Committee on Governance 25

4 cjhp California Journal of Health-System Pharmacy January/February Supplement 2018

VOL. 30 SUPPLEMENT 1CSHP mission

To Represent and Empower Pharmacists and

Pharmacy Technicians Practicing in Health-Systems to Promote

Wellness, Patient Safety and Optimal Use of

Medications

CSHP vision

Pharmacists are Recognized as Leaders in Wellness, Patient Safety and the Optimal Use of

Medications

CJHP (ISSN 1097-6337) is published bimonthly by the California Society of Health-System Pharmacists, 1314 H Street, Suite 200, Sacramento, CA 95814, under the guidance of the Editorial Advisory Board. The CJHP is distributed as a regular membership service, paid through allocation of membership dues. The subscription rate for non-members is $75 per year; single copies are $15. Periodicals postage paid at Sacramento, CA. Postmaster: Send address change to California Society of Health-System Pharmacists, 1314 H Street, Suite 200, Sacramento, CA 95814 (email: [email protected]).

The views expressed by authors of contributions in the California Journal of Health-System Pharmacy do not necessarily reflect the policy of CSHP or the institution with which the author is affiliated, unless this is clearly specified. Policy statements and official positions of CSHP are clearly labeled as such. The editor and publisher assume no responsibility for material contained in articles and advertisements published, nor does publication necessarily constitute endorsement by them. Letters to the editor are encouraged. Publisher reserves the right to edit, reject or publish whole or part of manuscripts submitted. No portion of this magazine may be reproduced, in whole or in part, without written consent of CSHP. © 2018 by the California Society of Health-System Pharmacists. Payments to CSHP are not deductible as charitable contributions for federal income tax purposes; however, they may be deductible under other provisions of the Internal Revenue Code.

For display and employment advertising, please contact CSHP Industry Relations at [email protected] or (916) 447-1033

Cover image: Geometric pattern

Peer Review

The California Journal of Health-System Pharmacy is a peer-reviewed publication!

The CSHP Editorial Advisory Board is pleased to announce that the California Journal of Health-System Pharmacy has completed the transition to peer review.

Peer reviewed, or refereed, publications utilize an editorial process to ensure that the articles published are as scholarly as possible. From this point forward, when an article is submitted to CJHP, the editors will send it out to other (peer) pharmacists and clinicians in the same field to obtain their opinion as to the appropriateness of the manuscript for publication, the relevance to the field of study, and the quality of the research.

Instructions for Authors

The California Journal of Health-System Pharmacy welcomes article submissions in any field pertinent to the practice of health-system pharmacy. All manuscripts submitted are subject to peer review. To submit a manuscript for publication, please visit http://cshpjournal.msubmit.net.

For more information on article submission, peer review, or CJHP, please contact Cindy Hespe, Managing Editor, CJHP at [email protected] or 916.447.1033.

Editor

Loriann De Martini, PharmD, BCGP

Managing Editor

Cynthia Hespe, RPh, FCSHP

Contributing Editors

Dianne Coker Megan Page Preena Lobo Ryan Yamamura

Design

HareLine Graphics

Editorial Advisory BoardPatrick Chan, Co-Chair Jason LamLaura Polonsky, Co-Chair Tristan LindfeltTodd Okamoto, Chair-elect Marcus RavnanGary Besinque Cathlene RichmondDiana Cao Sachin ShahJennifer Cupo Abbott Marcus RavnanAngelic Ervin Caroline SierraRon Floyd Cynthia Valle-OsegueraJackie Ho Andy Szeto

California Society of Health-System Pharmacists

Officers Dan Dong [email protected] President Steven J. Thompson [email protected] President-elect Vicky Ferraresi [email protected] Chair, Board of Directors Jeannette Hanni [email protected] Chair, House of Delegates Pauline Chan [email protected] Treasurer Loriann De Martini [email protected] Secretary

Directors Gary Besinque [email protected] Jennifer Cashman [email protected] Donna Fitzgerald [email protected] Amy Kang [email protected] Elaine Law [email protected] Marcie Lepkowsky [email protected] Mirta Millares [email protected] Helen Park [email protected] Jim Scott [email protected] Jim Walsh [email protected]


HO

D R

EPO

RT Report of the Forty-Second Annual Session of the CSHP House of Delegates

The forty-second annual session of the California Society of Health-System Pharmacists House of Delegates was held in the Concord A room of the Paris Hotel

in Las Vegas, Nevada, in conjunction with Seminar 2017, the Society’s annual meeting.

The CSHP House of Delegates (HOD) Chair Jeannette Hanni convened the meeting at 10:12 a.m. on Sunday, October 29, 2017.

Roll Call and QuorumFollowing the enrollment of delegates, Secretary Loriann De Martini reported that a quorum was present. Included are CSHP officers, directors, past presidents, and delegates representing CSHP-affiliate chapters, student delegates from each of the California schools of pharmacy, pharmacy technician members, and the California Pharmacists Association.

IntroductionsHOD Chair Hanni introduced CSHP CEO and Secretary of the House of Delegates Loriann De Martini, President Vicky Ferraresi, Chair of the Board of Directors Kethen So, President-elect Daniel Dong, Treasurer Pauline Chan, and Maria Serpa who served as the parliamentarian for the 2017 HOD.

Role and Function of the House of Delegates HOD Chair Hanni described the purposes and functions of the HOD and emphasized its responsibility for establishing policy. The number of delegates eligible to vote this year was 138.

Approval of Minutes from the 2016 CSHP House of DelegatesHOD Chair Hanni called for a motion to approve the minutes of the forty-first annual session of the CSHP HOD as published on the CSHP website. The minutes were approved by voice vote.

Report of the Blue Ribbon Committee on GovernanceDr. William Yee recognized members of the CSHP Blue Ribbon Committee on Gover-nance. Dr. Yee reported on the Blue-Ribbon Committee’s charge to review of CSHP’s administrative policies and provided a brief overview of the report.

Dr. Yee explained the difference between CSHP professional and administrative policy. This report was presented for the information of delegates and did not require action by the HOD.


HOD Report

CSHP Annual ReportHOD Chair Hanni reported that the CSHP Annual Report was presented at the CSHP business meeting held on Friday, October 27, in the Versailles Ballroom at the Paris Hotel in conjunction with CSHP Seminar 2017. The business meeting included reports from CSHP President Vicky Ferraresi, CSHP Treasurer Pauline Chan, and CSHP CEO Loriann De Martini. These reports will be available on the CSHP website as well as a special online issue of CJHP.

Report of the Committee on NominationsCSHP Committee on Nominations Chair Anne Tran-Pugh briefly explained the nomination process, then thanked Brian Kawahara for putting together the members for the 2017 Nomi-nation Committee. Dr. Tran-Pugh introduced and acknowledged the members of the 2016-2017 Committee on Nominations:

Name Chapter Anne Tran-Pugh (Chair) Orange County Elizabeth Chang Golden Gate Steve Dohi San Gabriel Valley Jerry Fujiwara Golden Empire Martin Iyoya Diablo Paige Lin Inland Betty Jue Quatra Joel Weber Sierra

The following nominees for CSHP offices were presented and approved:

For President-elect

Name Chapter Kenneth Perrin Sierra Steven Thompson SoBay/Long Beach

For Board of Directors, 3-Year Term

Name Chapter Norman Fox Sierra James Scott San Fernando Valley Robert Poole Quatra County Helen Park Quatra County

For New Practitioner Chair/Director, 2-Year Term

Name Chapter Amy Kang Orange County Susan Lee Golden Gate

For Delegates to the ASHP House of Delegates

Name Chapter Sandra Bardas Quatra County Victoria Serrano Adams Golden Gate Daniel Dong Golden Gate Vicky Ferraresi Quatra Steven Gray Inland Nancy Korman Golden Gate Kimberly Tallian San Diego Maria Serpa Sacramento Valley Robert Poole Quatra County Kristine Parbuoni Inland Jeannette Hanni Quatra County Steven Thompson SoBay/Long Beach Kethen So Golden Gate Alexander Cao SoBay/Long Beach Khaled Khoury Inland Kenneth Perrin Sierra

Dr. Tran-Pugh invited each of the nominees to stand and be recognized as she called their names and thanked them for their willingness to serve. Dr. Tran-Pugh moved for acceptance of the slate of candidates for the 2018 CSHP officers and board of directors. HOD Chair Hanni called for a vote and the slate was approved by voice vote.

HOD Chair Hanni thanked Dr. Tran-Pugh and the CSHP Committee on Nominations for their work in presenting a slate of candidates.

Action on Proposals and ResolutionsCSHP Board of Directors Chair Kethen So introduced 24 proposals and five resolutions on behalf of the CSHP Board for consideration by the HOD.

For the complete text and background materials for all proposals and resolutions presented at the 2017 CSHP House of Delegates, visit the CSHP website then choose “Policy,” then “2017 HOD,” or access via this link: http://www.cshp.org/page/2017_HOD_Materials.

HOD Chair Hanni proposed and asked the delegates to accept a process for accepting proposals and resolutions in mass, rather than discussing each individually. She then asked delegates which proposals would need further discussion and be excepted out. This excepting out process was approved by voice vote.

The following proposal was asked to be excepted out:


HOD Report

Proposal B.4: Timely Board of Pharmacy Licensing

Hanni then asked for resolutions which would need further discussion and be excepted out. The following resolution was excepted out: Resolution A: Change to the Composition of the California State Board of Pharmacy: Pending Legislation SB 716.

ProposalsProposal A: Pharmacy Technicians and Interns

A.1: Pharmacy Technician Training and Certification To replace CSHP policies 2012-09, 2013-10, and 2013-31 with ASHP Policy 1537 as CSHP Professional Policy 2017-01: Statement on the Roles of Pharmacy Technicians

Approved

Statement on the Roles of Pharmacy Technicians

The California Society of Health-System Pharmacists:

1. recognizes that pharmacy technicians have many different roles in a variety of health care settings, with varying levels of responsibility and complexity, from those suitable for techni-cians just entering the workforce to advanced or specialized roles that require additional education, training, experience, competence and compensation.

2. recognizes there is a need for specialized certification of pharmacy technicians who perform activities involving higher than normal degrees of complexity and risk. Any pharmacy technician in an area of pharmacy practice designated for specialty or advanced certification must have the appropriate certifications successfully completed prior to practicing in that specialty area.

3. recognizes that differing roles for pharmacy technicians will require advanced education and training beyond that of an entry-level technician. Education and training requirements must reflect the responsibilities that technicians will have in their daily activities. Ongoing competence assessment must be a component of advanced or specialized technician roles.

4. supports that pharmacy technicians, from entry-level to specialty-trained technicians, complete a pharmacy tech-nician training program accredited by ASHP and the Accreditation Council for Pharmacy Education (ACPE) through the Pharmacy Technician Accreditation Commis-sion (PTAC) as a requirement for earning PTCB certification or equivalent certification. A process should be developed to allow for grandfathering of qualified technicians.

5. supports that pharmacy technicians have either PTCB or equivalent certification as a prerequisite to licensure by the California Board of Pharmacy and maintain their certification through mandated continuing education and recertification.

A.2: Career Opportunities for Pharmacy Technicians

To accept and adopt ASHP Policy 1610 with modifications as CSHP Professional Policy 2017-02: Career Opportunities for Pharmacy Technicians

Approved

Career Opportunities for Pharmacy Technicians


1. promotes pharmacy technicians as valuable contributors to healthcare delivery.

2. develops and disseminates information about career opportu-nities that enhances the recruitment and retention of qualified pharmacy technicians.

3. supports pharmacy technician career advancement opportu-nities and compensation models that are commensurate with training and education.

A.3: Pharmacy Intern Positions

To replace CSHP Professional Policy 2013-18 with modifications as CSHP Professional Policy 2017-03: Role of Intern Pharmacists

Approved

Role of Intern Pharmacists


1. explores and promotes new staffing models that foster expanded roles for intern pharmacists, providing quality work and patient experiences that build upon their knowledge and help them develop as future pharmacists.


2017 Annual Report

Proposal B: Leadership and Professional Development

B.1: Leadership Development

To modify and adopt CSHP Policy 2015-43 as CSHP Professional Policy 2017-04: Leadership Development

Approved

Leadership Development


1. supports collaboration with healthcare organization leadership to foster opportunities, allocate time, and provide resources for pharmacy practitioners to move into leadership roles.

2. encourages leaders to seek out and mentor pharmacy practitioners in developing administrative, managerial, and leadership skills.

3. encourages pharmacy practitioners to obtain the skills necessary to pursue administrative, managerial, and leadership roles.

4. encourages colleges of pharmacy and CSHP chapters to collaborate in fostering student leadership skills through development of co-curricular leadership opportunities, leadership conferences, and other leadership promotion programs.

5. support that residency programs should develop leader-ship skills through mentoring, training, and leadership opportunities.

6. fosters leadership skills for pharmacists to use on a daily basis in their roles as leaders in patient care.

7. is committed to providing leadership development programs for its members.

B.2: Inter-Professional Education

To modify and adopt CSHP Policy #2014-58 as CSHP Professional Policy 2017-05: Inter-Professional Education and Training

Approved

Inter-Professional Education and Training


1. supports inter-professional education as a component of didactic and experiential education in Doctor of Pharmacy degree programs.

2. supports inter-professional education, mentorship and professional development for student pharmacists, student technician’s residents, and pharmacists and technicians.

3. encourages and supports pharmacists’ collaboration with other health professionals and healthcare executives in the development of inter-professional, team-based, patient-centered care models.

4. encourages documentation and dissemination of outcomes achieved as a result of inter-professional education of health-care professionals.

B.3: Cultural Competency

To combine the ASHP Policy 1613 with the CSHP Professional Policy 2015-09: as CSHP Professional Policy 2017-06: Cultural Competency

Approved

Cultural Competency


1. promotes the development of cultural competency of educa-tors, practitioners, residents, students, and technicians.

2. supports the education of providers on the importance of providing culturally congruent care to achieve quality care and patient engagement.

3. fosters awareness of the impact that a culturally diverse work-force has on improving health care quality.

B.4: Timely Board of Pharmacy Licensing

To update and replace CSHP Policy 2012-10 and adopt ASHP Policy 1621: Timely Board of Pharmacy Licensing as CSHP Profes-sional Policy 2017-07: Pharmacist Licensure

Approved as amended

Pharmacist Licensure


1. supports that the California State Board of Pharmacy should maintain its competency standards for pharmacist licensure.

2. acknowledges that the North American Pharmacist Licensure Examination (NAPLEX), combined with a California Practice Standard and Jurisprudence Examination (CPJE), is appro-priate to test for basic competencies essential for entry-level pharmacist practice if the examinations include, but are not limited to, testing for pharmacy principles and standards in:

a. patient consultation skillsb. application of clinical knowledge in a variety of patient care

settings


HOD Report

c. sterile and non-sterile compoundingd. drug distribution and e. medication safety

3. advocates that the California State Board of Pharmacy streamlines the licensure process through standardization and improve the timeliness of application approval.

Proposal C: Pharmacy Therapeutics and Distribution

C.1: Promotion of Off-Label Uses

To amend CSHP Professional Policy 2014-51 and adopt as CSHP Professional Policy 2017-08: Off-Label Use of Medication

Approved

Off-Label Use of Medication


1. supports the practice of prescribing medications for off-label uses that are documented in the medical literature in a system that:

a. maintains patient access to pharmacist review of all medications.

b. protects the pharmacist’s right of refusal of an off-label use of a medication.

c. preserves the patient-pharmacist-prescriber relationship. d. provides adequate patient counseling and education,

particularly to patients taking medications for off-label use. e. recognizes the prescriber’s responsibility in assuring the

appropriate and safe use of all medications and f. encourages evidence-based decision making and

prescribing.

2. opposes efforts to restrict the off-label use of medication when the usage is medically appropriate, evidence-based and in the patient’s best interest

3. supports the authority of the Food and Drug Administra-tion (FDA) to regulate the promotion and dissemination of information about off-label uses of medications and medication-containing devices by manufacturers and their representatives.

4. supports that such off-label promotion and marketing be limited to the FDA-regulated dissemination of unbiased, truthful, and scientifically accurate information based on peer-reviewed literature not included in the New Drug Approval process.

C.2: Home IV Therapy

To amend ASHP Policy 1623 and adopt the following as CSHP Professional Policy 2017-09: Home Intravenous Therapy

Approved

Home Intravenous Therapy


1. supports the continuation of a home intravenous therapy benefit under federal, state, and private health insurance plans.

2. supports expansion of the home infusion benefit under Medicare and Medi-Cal and other health plans at an appropriate level of reimbursement for pharmacists’ patient care services including patient and caregiver education, medications, supplies, and equipment to provide optimal therapy for patients.

3. encourages health-systems and providers to ensure that transitions of care into the homecare environment includes information and sufficient time for the home infusion pharmacy to provide the following in an optimal and timely manner:

a. coordination with other healthcare providers b. intravenous therapy c. medicationsd. ancillary supplies and equipment’se. education

C.3: Tobacco Products and Electronic Nicotine Devices

To amend CSHP Policy 2013-13 and adopt as CSHP Policy no 2017-10: Efforts to Discourage the Use of Tobacco Products

Approved

Efforts to Discourage the Use of Tobacco Products


1. supports smoke-free, tobacco-free, and electronic nicotine delivery systems (ENDs)-free environments, including CSHP-sponsored meetings and events.

2. encourages its members to participate in educational efforts to discourage tobacco use and encourages pharmacists who educate patients on tobacco cessation to obtain training as tobacco cessation educators.

3. promotes the role of pharmacists in tobacco cessation counseling and smoking cessations medication therapy management.


HOD Report

4. supports the elimination of the sale of tobacco products and ENDs from all California Pharmacies and all establishments that contain a pharmacy.

5. joins with other interested organizations in statements and expressions of opposition to the use of tobacco, tobacco prod-ucts, and electronic nicotine delivery systems.

6. supports patient accessibility to multiple tobacco cessation therapies.

C.5: Safety of Epidural Steroid Injections

Adopt the following as CSHP Professional Policy 2017-10: Safety of Epidural Steroid Injections

Rejected

Safety of Epidural Steroid Injections


1. supports the efforts of the California State Board of Pharmacy, the United States Food and Drug Administration, and the United States Pharmacopeia to ensure the safety, potency, and efficacy of sterile compounded medications.

2. encourages healthcare providers to inform patients about the significant risks and potential lack of efficacy of epidural steroid injections, request their informed consent, and inform patients of alternative therapies and their risks and benefits.

3. supports pharmacist involvement in the medication-use process associated with epidural steroid injections when such injections are medically necessary.

C.6: Controlled Substance Diversion

To amend CSHP Policy 2014-38 and adopt as CSHP Professional Policy 2017-11: The Role of the Pharmacist in Controlled Substance Abuse and Drug Diversion

Approved

The Role of the Pharmacist in Controlled Substance Abuse and Drug Diversion


1. endorses the ASHP Statement on the Pharmacist’s Role in Substance Abuse Prevention, Education, and Assistance.

2. recognizes the importance of balancing efforts to address legitimate pain issues and patient care.

3. recognizes that pharmacists have the unique knowledge, skills, and responsibilities in substance abuse and drug diver-sion prevention and education.

4. recognizes that pharmacists working collaboratively with other health professionals are actively involved in the identifi-cation and mitigation of substance abuse and diversion within health-systems.

5. recognizes that pharmacists, as health care providers, should be actively involved in reducing the negative effects that substance abuse has on society, health-systems, and the phar-macy profession.

6. recognizes that pharmacists play an active role in harm reduc-tion by furnishing opioid antagonist products.

C.7: Therapeutic Indication in CDS

To amend CSHP Professional Policy 2013-42 and adopt as CSHP Professional Policy 2017-12: Therapeutic Indication in Clinical Decision Support

Approved

Therapeutic Indication in Clinical Decision Support


1. supports the development of clinical decision support (CDS) systems that are proven to improve medication-use outcomes and that include the following capabilities:

a. the use of alerts, notifications, and summary data views provided to the appropriate people at the appropriate times in clinical workflows, based on:i. a rich set of patient-specific data,ii. standardized, evidence-based medication-use best prac-

tices, andiii. identifiable patterns in medication-use data in the elec-

tronic health record;b. audit trails of all CDS alerts, notifications, and follow-up

activity;c. structured clinical documentation functionality linked to

individual CDS alerts and notifications; andd. highly accessible and detailed management reporting

capabilities that facilitate assessment of the quality and completeness of CDS responses and the effects of CDS on patient outcomes.

e. support CDS systems to include medication indications on the prescription order


HOD Report

C.9: Automated Preparation and Dispensing Tech for Sterile Preps

To adopt the following as CSHP Professional Policy 2017-13: Auto-mated Preparation and Dispensing Technology for Sterile Preparations

Approved

Automated Preparation and Dispensing Technology for Sterile Preparations


1. supports the use of health information technology and other patient-care technologies for preparing and dispensing sterile preparations that improves the safety and reliability of the medication use process.

2. supports pharmacists and pharmacy technicians be included in key decision roles of a multidisciplinary team in the planning, selection, implementation, and maintenance of automated systems to facilitate preparation and dispensing of sterile preparations.

3. encourages the education of patient safety advocacy groups and regulatory agencies on the capabilities and benefits of automation and technology for preparing and dispensing compounded sterile preparations.

Proposal D: Review CSHP Professional Policies 5 Years or Older

D.1: Sports Pharmacy

To reaffirm CSHP Professional Policy 2012-02 as CSHP Profes-sional Policy 2017-14: Sports Pharmacy

Approved

Sports Pharmacy


1. encourages safe and healthy participation in competitive sport and exercising.

2. supports the pharmacist’s role in promoting safe and proper use of medications and nutritional supplements and recog-nizes the unique medication needs of athletes.

3. encourages the general public to seek health professional advice related to medications and nutritional supplements promoted for sports performance or used to maintain health.

4. supports the efforts of organizations to educate and enforce drug testing to discourage the use of banned and/or harmful performance-enhancing substances.

5. develops collaborative efforts with health and sport organiza-tions in order to educate athletes and others regarding the safe and most effective legitimate use of medications.

6. supports public and professional education campaigns in discouraging the use of banned and/or harmful performance-enhancing substances.

7. encourages members to offer consultation to athletes about the potential harm of using banned performance-enhancing substances.

8. encourages schools of pharmacy to develop education programs for students and pharmacists that address the safe use of medication recognizing the unique needs of athletes.

D.2: Computerized Prescriber Order Entry

To modify and reaffirm CSHP Professional Policy 2012-04 as CSHP Professional Policy 2017-15: Computerized Prescriber Order Entry

Approved

Computerized Prescriber Order Entry (CPOE)

The California Society of Health-System Pharmacists advocates for and supports the use of computerized entry of medication orders or prescriptions when:

1. it is planned, implemented, and managed with pharmacists’ involvement.

2. such orders are part of a single, shared database that is inte-grated with the pharmacy information systems, electronic health record, and other key information system components such as the patient’s medication administration record.

3. such computerized order entry improves the safety, efficiency, and accuracy of the medication-use process.

4. such computerized order entry includes clinical decision support systems.

5. it includes provisions for the pharmacist to review and verify the order’s appropriateness before medication administration, except in those instances when review would cause a medi-cally unacceptable delay.

D.3: Non-Pharmacist and Prescriber Dispensing

To modify and reaffirm CSHP Professional Policy 2012-05 as CSHP Professional Policy 2017-16: Non-Pharmacist and Prescriber Dispensing

Approved


HOD Report

Non-Pharmacist and Prescriber Dispensing


1. supports - legislative and regulatory controls establishing the requirements for non-pharmacist and prescriber dispensing.

D.4: Recovering Pharmacy Professionals

To modify and reaffirm CSHP Policy 2012-06 as CSHP Profes-sional Policy 2017-17: Recovering Pharmacy Professionals

Approved

Recovering Pharmacy Professionals

The California Society of Health-System Pharmacists

1. encourages members to support and participate in the State of California’s Pharmacist Recovery Program, which identi-fies and rehabilitates pharmacists and pharmacy interns with impairment due to the misuse and abuse of dangerous drugs and substances or due to mental illness.

2. encourages that the California State Board of Pharmacy also include pharmacy technicians in the State of California’s Phar-macist Recovery Program.

D.5: Pharmacist Involvement in Student Pharmacist Education

To modify and reaffirm CSHP Professional Policy 2012-07 as CSHP Professional Policy 2017-18: Pharmacist Involvement in Student Pharmacist Education

Approved

Pharmacist Involvement in Student Pharmacist Education


1. encourages pharmacists and pharmacy leaders to recognize that part of their professional responsibility is the develop-ment of student pharmacists.

2. encourages pharmacist’s participation in the training and education of student pharmacists through involvement with independent internship programs and/or with school of phar-macy sponsored practice-based experience programs. The achievement of predetermined competencies should be the primary objective of all such programs.

3. encourages schools of pharmacy to define and develop appro-priate organizational relationships that permit a balance of patient care and professional and community service.

4. encourages schools of pharmacy to collaborate with pharmacy organizations on the development of standards to enhance the quality of experiential education and pharmacist’s preceptor.

5. supports the provision of tools, education, and other resources to develop preceptor skills.

6. encourages all educators use ASHP guidelines, statements and profession policies as an integral part of the educational process.

D.6: Productivity Measurement Systems

To modify and reaffirm CSHP Professional Policy 2012-08 as CSHP Professional Policy 2017-19: Productivity Measurement Systems

Approved

Productivity Measurement Systems


1. opposes the development of a standardized format and defini-tions for creating a productivity measurement system for pharmacies in California.

D.7: Technician Regulations

To modify and reaffirm CSHP Professional Policy 2012-09 as CSHP Professional Policy: Technician Regulations

Rejected and replaced with CSHP Professional Policy 2017-01: Statement on the Roles of Pharmacy Technicians (proposal A.1)

Technician Regulations


1. Supports efforts by the pharmacy profession through regu-latory and/or legislative changes that broaden the scope of practice for pharmacy technicians.

2. CSHP advocates that the profession of pharmacy move toward the following model with respect to pharmacy techni-cians as an approach to protecting public health and safety:

a. Development and adoption of uniform state laws and regu-lations regarding pharmacy technicians;

b. Mandatory completion of an ASHP accredited pharmacy technician training program as a prerequisite to pharmacy technician certification; and

c. Mandatory certification by a single nationally validated, psychometrically sound examination approved by the state board of pharmacy as a prerequisite to the state board of pharmacy granting the technician permission to engage in the full scope of responsibilities authorized by the state.

3. To continue to advocate licensure of pharmacy technicians by the state board of pharmacy.

4. To advocate as an interim measure (until the optimal model is fully implemented) that individuals be required either


HOD Report

a. to have completed an ASHP accredited pharmacy techni-cian training program or

b. to have at least one year of equivalent experience as a pharmacy technician before they are eligible to become licensed.

D.8: Repackaging of Pharmaceuticals for Distribution

To modify and reaffirm CSHP Professional Policy 2012-12 as CSHP Professional Policy 2017-20: Repackaging of Pharmaceuti-cals for Distribution

Approved

Repackaging of Pharmaceuticals for Distribution


1. supports the practice of pharmacies performing bulk repack-aging of pharmaceuticals for distribution outside the facility in which that pharmacy is located or licensed in accordance with California Board of Pharmacy regulations and the Food and Drug Administration guidelines and regulations.

D.9: Safe Handling of Cytotoxic and Hazardous Drugs

To modify and reaffirm CSHP Professional Policy 2012-13 as CSHP Professional Policy 2017-21: Safe Handling of Cytotoxic and Hazardous Drugs

Approved

Safe Handling of Cytotoxic and Hazardous Drugs


1. recommends that each hospital, health-system, other patient care facility, or environment where cytotoxic or hazardous drugs are handled, stored or administered establish guide-lines on the safe handling of chemotherapeutic, cytotoxic and hazardous drugs based on State and Federal laws and regula-tions and the best practices and/or guidelines from nationally recognized organizations.

D.10: Nuclear Pharmacy

To modify and reaffirm CSHP Professional Policy 2012-14 as CSHP Professional Policy 2017-22: Nuclear Pharmacy

Approved

Nuclear Pharmacy


1. supports that the responsibility for the preparation and distri-bution of radiopharmaceuticals for human and veterinary use shall be delegated only to specially trained pharmacists, as defined by the Board of Pharmacy, in the area of nuclear pharmacy.

D.11: Increased Security Features on Controlled Substances Prescription Form

To modify and reaffirm CSHP Professional Policy 2012-15 as CSHP Professional Policy 2017-23: Increased Security Features on Controlled Substances Prescription Form

Approved


1. supports standardization of the controlled substance prescrip-tion security forms and improving the security feature requirements on those forms.

2. supports accountability regulations that require controlled substance prescription form printers to inform law enforce-ment if their products are stolen or their company identity is stolen.

3. encourages the development and use of real-time electronic verification methods.

ResolutionsA total of five resolutions were presented to the CSHP House of Delegates.

Resolution A: Change to the Composition of the California State Board of Pharmacy: Pending Legislation SB 716

A motion was passed to divide the proposed action items of Resolution A, into two separate resolutions, namely A1 and A2.

Resolution A.1: Addition of a Pharmacy Technicians to the California State Board of Pharmacy

To adopt as CSHP Professional Policy 2017-24: Addition of a Pharmacy Technician to the California State Board of Pharmacy

Approved as amended

Addition of Pharmacy Technicians to the California State Board of Pharmacy

California Society of Health-System Pharmacists:

1. supports the inclusion of pharmacy technicians on the Board of Pharmacy.


HOD Report

During the discussion of Resolution A.2: Pharmacist Majority on the California State Board of Pharmacy, a two-minute break was taken to allow the parliamentarian and presidential officers to verify Article V of CSHP Bylaws regarding the allowance of a non-delegate the privilege of the floor. Upon clarification of the CSHP Bylaws, a recount indicated 106 delegates in atten-dance and verified a quorum. A motion was approved to allow a non-delegate member, Daniel Kudryashov, to address the CSHP House of Delegates regarding Resolution A.2.

Resolution A.2:

To adopt as CSHP Professional Policy: Pharmacist Majority on the California State Board of Pharmacy

Referred back to CSHP Board of Directors for further action.


1. supports the composition of the California State Board of Pharmacy to be constituted by a majority membership of licensed pharmacists to insure public safety.

Resolution B: Mandatory Labeling of the Presence of Natural Rubber Latex in Medications

To adopt as CSHP Professional Policy 2017-25: Mandatory Labeling of the Presence of Natural Rubber Latex in Medications

Approved

Mandatory Labeling of the Presence of Natural Rubber Latex in Medications


1. urges the Food and Drug Administration to mandate that manufacturers of medications and medication-device combi-nation products include labeling information on whether any component of the product, including its packaging, contains natural rubber latex.

Resolution C: Preventing Exposure to Allergens in Medications

To adopt the following as CSHP Professional Policy 2017-26: Preventing Exposure to Allergens in Medications

Approved

Preventing Exposure to Allergens in Medications


1. urges pharmacy participation in the collection, assessment, and documentation of a complete list of allergens pertinent to medication therapy, including food, natural rubber latex, excipients, medications, devices, and supplies, for the purpose of clinical decision-making; further,

2. encourages vendors of medication-related databases incor-porate and maintain information about medication-related allergens and cross-sensitivities; further,

3. recommends that all pharmacists actively review allergens pertinent to medication therapy and minimize patient and healthcare worker exposure to known allergens, as feasible; further,

4. encourages education of pharmacy personnel on medication-related allergens.

Resolution D: Excipients in Medication Products

To adopt the following as CSHP Professional Policy 2017-27: Excipients in Medication Products

Approved

Excipients in Medication Products


1. supports the removal of unnecessary, potentially allergenic excipients from all medications; further,

2. encourages manufacturers to declare the name and derivative source of all excipients in medications on the official label; further,

3. strongly encourages that vendors of medication-related data-bases incorporate information about excipients; further,

4. fosters education on the allergenicity of excipients and docu-mentation in the patient medical record of allergic reactions to excipients.

Resolution E: Safe and Effective Use of Medications in Pediatric and Neonatal Patients

To adopt the following as CSHP professional policy 2017- 28: Safe and Effective Use of Medications in Pediatric and Neonatal Patients

Approved

Safe and Effective Use of Medications in Pediatric and Neonatal Patients


1. supports that pharmacy services should be provided with sufficient physical facilities, personnel, and equipment to meet the pharmaceutical care needs of the pediatric and neonatal population. This includes orientation and training programs for pharmacists and pharmacy technicians providing services to pediatric and neonatal patients including emphasizing dosage calculations and dosage-form selection appropriate to


HOD Report

patient's age and condition as well as specialized drug prepa-ration and techniques.

2. recognizes that pharmacists and pharmacy technicians who are trained, qualified, and/or who possess expertise in pedi-atric pharmacotherapy or skills should be integrated within the interdisciplinary health care team in order to reduce the rates of potential and preventable adverse drug events in pedi-atric and neonatal patients including:

i. Promoting safe and effective medication use practices in this patient population

ii. Counseling and educating patients and caregivers on their medications

iii. Creating appropriate dose standardization in oral and parenteral drug distribution systems

3. supports the expansion of pharmacy education and postgrad-uate residency and fellowship training on pediatric pharmacy and/or pharmacotherapy and the inclusion of pharmacists when conducting pediatric research.

4. supports the development and use of nationally standard-ized concentrations of medications as well as advocates that hospitals and health systems use manufacturer-prepackaged products when possible to improve the safe use of medica-tions in pediatric and neonatal patients.

Approval of the 2017-2018 Committee on NominationsHOD Chair Hanni reported that during the 2017 CSHP Stra-tegic Planning meeting, the Committee on Nominations’ name was changed to the Committee on Nomination and Leadership Development. Ms. Hanni presented the House of Delegates with a list of members proposed for approval as members of the 2017-2018 Committee on Nominations and Leadership Devel-opment. She advised that the recommended appointments had been reviewed and approved by the CSHP Board of Directors as required by CSHP Bylaws, will serve as a committee of the House of Delegates, and presented the list to the House of Delegates for approval.

Nominee Chapter

Martin Iyoya (Chair) Diablo Nancy Korman Golden Gate Kirsten Balano North Coast Maria Serpa Sacramento Valley Bob Miller San Diego Kenn Horowitz South Bay/Long Beach Jay Rho Southern California

The HOD approved the 2017-2018 Committee on Nominations and Leadership development as proposed.

New BusinessNo new business was submitted to the CSHP House of Delegates.

Delegate RecommendationsCSHP delegates provided the following recommendations to the HOD:

1. Recommended that the CSHP Board of Directors reevaluate the impact of California State Board of Pharmacy change in regulations to allow schools of pharmacy to grant all intern hours necessary to sit for the pharmacist licensure exam.

Recommended by: Scott Takahashi, Past President

2. Bonnie Fabian, on behalf of the Golden Gate chapter, announced a total donation of $1463 to PAC which is a combination of member donations and matching PAC funds from the chapter. She challenged other chapters to follow Golden Gate in their donations towards PAC.

Recommended by: Bonnie Fabian, GGSHP

3. Recommended that the CSHP Board of Directors work towards additional educational opportunities for students, residents and new practitioners, for financial aid awareness, and to request assessment on the rising cost of pharmacy education.

Recommended by: Bonnie Fabian & Michael Trillanes, GGSHP

4. Recommend that CSHP creates a new membership category recognizing members who have been belonged to the organi-zation for 50 years or more.

Recommended by: William Yee, Past President

5. Recommends that CSHP advocate directly (CA reps) and indirectly (with ASHP) to support HR3991: Expanded Access to Opioid Abuse Treatment Act of 2017.

Recommended by: Kathleen Besinque, SCSHP

Installation of PresidentOutgoing CSHP President Vicky Ferraresi installed Daniel Dong as CSHP’s new president and presented Dr. Dong with an inscribed CSHP president’s pin. Dr. Dong spoke briefly about his vision for the society including the goal of increasing member-ship and addressing legislative issues. He challenged every person in attendance to recruit one new member within the next year.


HOD Report

Recognition of Outgoing President & installation of the New Chair of the BoardNewly-installed President Daniel Dong called the immediate Past President Vicky Ferraresi to the podium. President Dong thanked Dr. Ferraresi for her leadership for the past year as president as well as her many years of service on the Board of Directors and to CSHP. Dr. Ferraresi was presented with a plaque on behalf of the membership and the Board of Directors to commemorate her year as president of CSHP. Dr. Ferraresi addressed the House and shared that serving as CSHP presi-dent was the greatest honor of her life. She thanked those who offered support during her tenure and vowed support to incoming President Dan Dong.

Recognition of Outgoing Chair of the Board of DirectorsImmediate Past President Vicky Ferraresi called outgoing Chair of the Board Kethen So to the podium and thanked him for leadership on the Board and contributions to the society. Dr. Ferraresi presented Dr. So, with an inscribed plaque to commem-orate his years as a Board member and as the chair of CSHP’s Board of Director.

Dr. So addressed the gathering and said the past three years on the board were challenging, but also the most rewarding and fun three years. Dr. So added that the Society’s membership has risen and is in a strong financial position. He thanked Loriann De Martini for the tremendous change she has brought to the Society within a year of her appointment as the CEO. Dr. So also thanked the CSHP staff for their hard work and contribution to bring CSHP back on track. He also thanked the CSHP member-ship for their trust and support of him over the last three years. Lastly, he also thanked the presidential officers and the board members past and present for their support and friendship.

Recognition of CSHP ParliamentarianHOD Chair Jeannette Hanni recognized Dr. Maria Serpa and thanked her for serving as parliamentarian during the proceed-ings of the 2017 House of Delegates.

AnnouncementsHOD Chair Jeannette Hanni reminded delegates that Seminar 2018 would be held in San Diego, California, on October 4-7, which is earlier than normal. Delegates were informed that the date for the 2017 Regional Delegates Conference will be earlier this year in August, will be decided by the CSHP Board of Direc-tors at its January meeting, and a ‘save the date’ notification will follow from the CSHP office.

AdjournmentHOD Chair Hanni pronounced the forty-second annual session of the CSHP House of Delegates adjourned at 11:59 p.m. o


HOD Report

Officers and Directors

Vicky Ferraresi Kethen So Daniel Dong Loriann DeMartini Pauline Chan Annet Arakelian Donna Fitzgerald Elaine Law Gary Besinque Jennifer M Cashman Jim Walsh Marcie Lepkowsky Mirta Millares Nicole Y. Nguyen Norman Fox

Past Presidents

Christine Antczak Steven Gray Kenneth Horowitz Robert Ignoffo Donald Kishi Nancy Korman Julie Lenhart Robert Miller Stacey Raff Frank Saya Kenneth Schell Scott Takahashi William Yee

Parliamentarian

Maria Serpa

California Pharmacists Association

Ethan Huynh Vinson Lee

California Northstate University Student Chapter

Que Huynh

Chapman University Student Chapter

Jaylene Lu

Central Valley

Andrea Hinton Yvonne My-Y Mai Greg Matsumura

California Health Sciences University Student Chapter

Kc Yovino

Diablo

Alfonso Becerra Lucian Cheng Derek Dwinell Natalie Fan Grace Ng Edlen Wong Lester Wong Johnny W Wong Keith Yoshizuka

Golden Empire

Jerry Fujiwara

Golden Gate

Bonnie Fabian Johnny Rau Sylvia Stofella Michael Trillanes

Inland

Patty Gray Kristine Parbuoni Bill Templeman Dale Timothy

Keck Graduate Institute Student Chapter

None

Loma Linda Student Chapter

Christian Gaoiran Rena Sackett

North Coast

Ken Chee Robyn Richard

Orange County

Dennis Andrew Ancheta Jack Chen Douglas Monroe Robert Stein Anne Tran-Pugh

University of the Pacific Student Chapter

Emily Hou Brandon Le

Pharmacy Technician E xecutive Committee

Tom Harper Richard Nunez

Quatra Country

Sandra Bardas Connie Ha Betty Lee Helen Park Jennifer Pham Lawrence Troxell

Sacramento Valley

Jason Bandy Michael Gonzales Grant Lackey Jennifer Lackey Praveen Reehal

San Diego

Therese Clark Jennifer Floyd Rebecca Kandilian Nightingale Meyou

San Fernando Valley

Vahe Apelian Nogie Demirjian Robert Small

San Gabriel Valley

Leslie Berina Grace Chen Jason Chen Fred Mock Selina Soohoo

Sierra

Bethanne Carpenter Shelly Hilliard Travis Pham

South Bay/Long Beach

Tim Chou Angela Lee Cindy Odegard Rosalin Preechakul Steven Thompson

Southern California

Paul Donatoni Kathleen Besinque Megan Besinque Joanna Lee John Sang Mei Wong

Touro University Student Chapter

Mylien Hoang Cindy Nguyen

UCSD Student Chapter

Lucy Chen Allison Cid

UCSF Student Chapter

Alexi Kimura

USC Student Chapter

Sandy On Devin Panlasigui

Western University Student Chapter

Angineh Moradi Masihi Hong Kong Tran

Delegates2017 CSHP House of Delegates, October 29, 2017

REPO

RT O

F TH

E PR

ESID

ENT 2017 CSHP Business Meeting

Report of the President October 27, 2017 Seminar 2017 Paris HotelLas Vegas, NV

Victoria Ferraresi, PharmD, FASHP, FCSHP

Good morning. I stand before you as my presidential year comes to a close. 2017 has been a year of transition for CSHP. It’s been our first full year with Loriann

De Martini as our CEO. She is the leader we need, AND she is a pharmacist.

Thanks to the tireless efforts of Dr. De Martini, Chairman of the Board Kethen So, the Board of Directors, and CSHP volunteers and staff, I can wholeheartedly assure you that CSHP is in good hands and headed in the right direction. You have heard that member-ship is increasing, and Treasurer Pauline Chan will report on our improving financial status. We have lots of plans for new services and programs for our members in 2018. Stay tuned as we roll them out. But now let’s take a look back at what CSHP has accom-plished during my presidential year.

We re-established the CSHP Sterile Compounding Committee. This group, ably led by Co-Chairs Maria Serpa and Doug O’Brien, is working to provide updated tools and resources for our members. They will report on their work to date at the Sterile Compounding Town Hall later today.

The Blue Ribbon Committee on Governance continued their work in 2017. This year they were charged with reviewing and reorganizing the CSHP Board Administrative Policy Catalog. Administrative policy guides the Society in providing activities and services for members. It is an essential component of CSHP operations. The committee has completed their charges and has done a fantastic job. Chairman Bill Yee will present their report at the House of Delegates on Sunday. Their work will no doubt improve how CSHP provides services for you, our valued members.

In August, the CSHP Board of Directors updated the strategic plan to identify five key initiatives to further our strategic priorities. They are:

• To promote the appropriate use of opioids via opioid stewardship

• To advance the professionalism of pharmacy technicians

• To provide leadership development for pharmacy professionals

• To promote implementation of pharmacist provider status

• To advance adherence to sterile compounding requirements



CSHP President’s Report

We will focus on these in the coming twelve to eighteen months. To that end, President-Elect Dan Dong has appointed the CSHP Opioid Stewardship Task Force. Over fifty members volunteered to serve. I look forward to their work in this critical area, providing guidance, strate-gies, and tools to assist you in managing this dire problem.

Legislatively, CSHP was the sponsor of SB716, authored by Senator Ed Hernandez, proposing to add a phar-macy technician to the California State Board of Pharmacy. We saw this as a step toward advancing the professionalism of pharmacy technicians and promoting the implementation of pharmacist provider status. Following an amend-ment to also add another public member and some members’ concern about the decreased pharmacist majority on the Board of Pharmacy, CSHP listened to our members. We held an affiliate chapter presidents’ phone call, had discussions with the affiliate chapters, and conducted a telephonic town hall. Subsequently, we asked Senator Hernandez to place a pause on the bill.

Next week, at the request of CSHP, Senator Hernandez is convening a meeting of stakeholders to discuss options

for the future of the bill. Stay tuned for developments. You are invited and strongly encouraged to participate in a discussion about SB 716 and other CSHP issues at the Seminar Town Hall, Open Forum, and at the end of this session.

All of our other CSHP Committees, Councils and Task Forces have been hard at work on the following:

• Monitoring legislation

• Operationalizing our strategic plan

• Identifying leaders

• Increasing membership

• Planning Seminar 2017 and 2018 and the CE that goes along with it

• Publishing our journal

• Keeping us updated on current health-care issues

• Serving our students, technicians, and new practitioners

• Recognizing achievements

As directed by last year’s House of Delegates, the CSHP Board of Direc-tors established a Code of Conduct Committee. Adding to The Event Code of Conduct created in 2016 is an incident

report form and a procedure for enforce-ment. We hope that these will never need to be used, but they will provide clear guidance and direction for action in case you need them.

To introduce candidates for CSHP office by more than an election bulletin, we are introducing a “Meet the Candidates” session at the end of the Open Forum. Candidates will be part of a panel and will answer questions on pharmacy practice and more. Also, be sure to check out the candidate videos on the CSHP website.

Not everything we accomplished in 2017 was innovative or glitzy and exciting. But it was important, strategic and sorely needed to restore your confidence.

It has been an extreme honor to be CSHP President. On Sunday I can turn the reigns over to my long-time friend and colleague Dan Dong knowing that the organization is in an improved position. Thank you for showing your faith and confidence in allowing me to have played a part in that. o

2017 CSHP Business Meeting Report of the Treasurer October 27, 2017 Seminar 2017 Paris HotelLas Vegas, NV

Pauline Chan, RPh, MBA, FCSHP, FASHPREPO

RT O

F TH

E TR

EASU

RER

This marks my first year as Treasurer of the California Society of Health System Pharmacist (CSHP). This report covers the fiscal year ending June 30, 2017.

Financial Highlights1. CSHP assets at year end totaled $ 2,766,620.

2. Net membership dues at year end totaled $362,727 which is lower than last year. We believe this is due to changes in leadership and in the membership renewal cycle.

3. CSHP contingency reserve funds at year end totaled $250,778.

4. Seminar 2016 netted in higher than expected revenue, to a total of $1,227,139, and with a net profit of $907,212.

5. With the departure of the executive vice president and the director of operations in 2015, CSHP incurred unanticipated legal and consulting expenses. Some of these expenses were incurred in year ending June 30, 2017.

6. CSHP continues a series of proactive cost cutting measures, with reduced travel and not filling personnel vacancies.

Independent Auditor’s ReportA financial audit was conducted by Fechter & Company, a CPA firm located at 1870 Avondale Avenue Suite 4, in Sacramento, California. The auditor’s report ending June 30, 2017, was presented at the CSHP Committee on Finance Meeting on September 26, 2017, and presented to the full CSHP Board of Directors by conference call on September 27, 2017.

A complete set of this report may be obtained by contacting the CSHP office at 1314 H Street, Suite 200, Sacramento, CA 95814. A copy of the report may be viewed during Seminar at the help desk.



CSHP Treasurer’s Report

Statement of Financial Position for Fiscal Year Ending June 30, 2017The Statement of Financial Position as of June 30, 2017 showed that CSHP’s total assets were $2,766,620. Our cash and cash equivalents were $302,998. Our total liabilities including accounts payable, accrued expenses, long-term debt and deferred revenue were $2,515,842.

Table 1 provides a schedule of our assets as reported in the prior three fiscal years.

Statement of Activities for Fiscal Year Ending June 30, 2017The CSHP Statement of Activities provides our revenue and other support and expenses. CSHP reported $1,907,009 in total revenue and $1,962,869 in total expenses. The net asset for the year decreased to $250,778.

We received net revenue of $362,727 from total membership dues, $1,227,139 from Seminar 2016 registration and exhibits fees, $61,743 from Founda-tion contract revenue, $60,781 in other income, $163,405 in rental income, $31,211 in journal advertising, and $3 in investment income.

Assets 2015 2016 2017

Cash and Cash Equivalents $ 60,810 $ 177,969 $ 302,998

Accounts Receivables 141,458 75,771 49,466

Prepaid Expenses 1,173 10,865 3,211

Investments 47,050 5,008 -

Property and Equipment (Net) & Other Assets

2,546,369 2,473,918 2,410,945

Total Assets $ 2,796,860 $ 2,743,531 $ 2,766,620

Table 1. CSHP Assets

Table 2. CSHP Revenue/Income

Revenue/Income 2015 2016 2017

Membership Dues* $ 493,371 $ 387,918 $ 362,727

Advertising and Publication Sales 50,635 56,693 31,211

Seminar Registration and Exhibits - - 1,227,139

Education Programs 1,419,707 1,150,478 -

Grant Income 171,453 - -

Foundation Contract Revenue - - 61,743

Rental, Investments and Other Income 162,371 164,482 224,189

Total Revenues $ 2,297,537 $ 1,759,571 $ 1,907,009

*less chapter rebates

Table 3. Net Assets

2015 2016 2017

Net Asset by year $ 355,281 $ 317,984 $ 250,778

Table 4. Ten-Year Trending of Net Income

2006 FY 2007 FY 2008 FY 2009FY 2010 FY 2011 FY 2012 FY 20013FY 2014 FY 20015 FY 20016 FY 20017 FY

Current Assets 1,106,602 1,136, 568 1,121, 728 428,792 441,146 545,016 464,582 679,543 425,696 250,491 244,857 355,675

Current Liabilities 388,175 428,903 474,809 617,964 581,210 709,298 625,164 914,016 605,213 683,885 728,555 863,499

Current Ratio 2.85 2.65 2.36 0.69 0.76 0.77 0.74 0.74 0.70 0.37 0.34 0.41

Net Income (loss) 84,797 (18,166) (45,668) (14,872) (14,945) (12,734) 3,851 (93,760) 71,998 (168,765) (48,643) (55,860)

Depreciation 15,742 22,128 22,128 25,848 96,657 96,116 93,006 102,750 95,181 101,525 102,309 90,941

EBITDA 100,539 3,962 (23,540) 10,976 80,712 83,382 96,857 8,990 167,179 (67,240) 53,666 35,081

Net Membership dues revenue

421,554 407,702 390,898 450,051 402,358 451,632 514,855 555,913 440,014 493,371 387,918 362,727


CSHP Treasurer’s Report

Table 2 provides a schedule of our revenue/income as reported in the previous three years.

Statement of Cash Flows for Fiscal Year Ending June 30, 2017The CSHP Statement of Cash Flow show operating activities was $149,020 and investing activities was $(210). Net cash provided by financing activities was $(28,789). Cash and cash equivalent at the beginning of the Year was $182,977 and at the end of the year was $302,998.

Reserve FundsReserve funds for year ending June 30, 2017 (also known as total net assets or equity), was $250,778. This compares to 2016 reserves of $317,894. Our reserves are equivalent to about 12.7% of current annual expenses.

Table 3 provides a schedule of our net assets compared to the prior three fiscal years.

Total revenue and other support was recorded at $1,907,009, with expenses for the year ending June 30, 2017, recorded at $1,962,869. This represents a decrease in net assets of $(55,860), also negatively impacting the reserves. Part of the decrease in net assets is due to building depreciation.

Current Ratios and Other StatisticsThe ten-year trending of current ratios, which is a ratio of current assets divided by current liabilities, shows a significant drop in the year ending June 30, 2009. This is due to the use of funds to purchase the office building, now recorded as prop-erty and equipment asset. Current ratios reached the lowest in 2015 and 2016, due to the legal expense as a result of the executive staff turnover. However, the current ratio has improved in 2017.

When viewing the ten-year trending of net income (Table 4), using earnings before interest, tax, depreciation and amortization (EBITDA), the current year shows a gain in EBITDA.

Cost of Services per MemberAs required per CSHP Administrative Policy, the cost of providing services per member in year ending June 30, 2017, was $323.80. The cost per member in year ending June 30, 2016, was $425.56. This represents a decrease/increase of 24% from 2016.

Controls and Fiscal AccountabilityOur certified, independent account, Craig Fechter, CPA, determined that the financial statements represent fairly, in all material respects, the financial position of CSHP as of June 30, 2017. The changes in its net assets and its cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.

ConclusionThis year, our new CEO has been working tirelessly with the CSHP Board of Directors and staff to provide high quality services for our members and to strengthen our financial positions. There has been a gradual increase in member-ship, particularly in the “new practitioner” category. With a steady revenue, we are able to provide additional member services, including certificate programs.

I’d like to thank all the members of CSHP for allowing to me to serve as the trea-surer over the past year. The time spent with CSHP members has been very rewarding. I forward to serving you for the remainder of my term. o


2017 CSHP Business MeetingReport of the CSHP CEO October 27, 2017 Seminar 2017 Paris HotelLas Vegas, NV

Loriann De Martini, PharmD

REPO

RT O

F TH

E CS

HP

CEO

Good morning. It has been a little over a year since I joined CSHP and its been a productive year. A year of rebuilding, growing, and embracing opportunities to bring

value to our members

I want to take a few minutes to share some highlights. First starting with membership:

• Since January 2017, our total membership has increased 61% (2672 to 4314).

• The greatest growth was in the category of new practitioner year 1 with a six to seven-fold increase (56 to 436) followed by the pharmacist category with a 165% increase (1084 vs 655).

• Our current membership numbers mirror our performance in fiscal year 2014, the time between July 2013 and June 2014.

• You may be wondering does our membership number equate to increased revenue? Absolutely, our current fiscal year started July 1, we are just about one-third of the way into the year, and we are at 65% of the projected goal for membership dues. One-third in and already two-thirds of the way to goal!

• Our performance is part of a positive membership growth trend over the last two years. In fiscal year 2015-16 (ending June 2016), we achieved 41% of the membership dues goal; however, in fiscal year 2016-17 (ending June 2017), we achieved 86% of our membership dues goals.

• Speaking of revenue goals, for our total revenue goals inclusive of membership dues, Seminar and sponsors, we are at 73% of goal (goal = $2,057,413, current = $1,509,421) and we are only one-third of the way into our fiscal year. At this pace, we should have one of our best years.

• And our student membership is growing with the addition of a new student chapter. A big welcome to West Coast School of Pharmacy.


CSHP CEO Report

Moving to our Seminar highlights:

• Our total attendance as of yesterday afternoon is 2,105, and exceeds our attendance at Disneyland last year. This may very well increase with onsite registration. Our attendance is 10% higher than we were in Las Vegas in 2012.

• Participation has increased in many areas:

o Poster sessions: 150 o Residency Showcase: 102o CV review: a whopping 149, and

a big thanks to the 50 volunteers who agreed to review and provide feedback

• A first for us is the pre-Seminar certificate programs covering advance practice pharmacist with an emphasis on chronic disease, pharmacoge-nomics, and transitions of care. Many thanks to our amazing partners who made this happen.

• We are currently on track to exceed our projected gross revenues by 12% (goal is $1,073,650, and we are currently at $1,204,084), and it may be one of our best Seminars, however, the final numbers won’t be in for a while.

What is on the horizon:

• We are launching a spring confer-ence (April 27-28, 2018) – the West Coast Preceptor Training Conference. Our goal is to create an environment that facilitates peer-to-peer learning while fostering and strengthening the preceptor community. The event will be held at the Asilomar in Monterey. Stay tuned for more information.

• Some may have heard about the recent establishment of the California Future Health Work Force Commission with the goal to identify a strategic plan to address the health work force needs for the next 30 years. The Commis-sion will be supported by a Technical Advisory Committee composed of about 30-plus appointed representa-tives across the healthcare continuum. I am pleased to say that last month I was appointed to the Technical Advisory Committee and will serve in the capacity of representing phar-macy professionals and provision of pharmaceutical care across all practice settings. This is an honor I don’t take lightly. To be the best representa-tive of all pharmacy professionals, I have personally reached out to other pharmacy associations and vested stakeholder to seek their input to inform my representation.

It has been a productive year. I personally want to thank the CSHP Board of Directors for their strong commitment and dedication. Your board has been meeting monthly instead of the usual quarterly. Without their dedication, support and guidance, much of what has been accomplished wouldn’t have been possible. Equal in their dedication, hard work and commitment, is the CSHP staff. I can honestly say without them and their tireless efforts most of what you have experienced would not have been possible.

Thank you for allowing me to serve as your CEO and I am hopeful that this time next year I will have more positive news of our growth, policy influence, and value to our members. o


2017 CSHP Business Meeting Report of the CSHP Blue Ribbon Committee on GovernanceOctober 27, 2017 Seminar 2017 Paris HotelLas Vegas, NV

William Yee, PharmD, FCSHP, FASHP

REPO

RT O

F TH

E CS

HP

BLU

E RI

BBO

N C

OM

MIT

TEE

ON

GO

VERN

AN

CE

The Charter of the CSHP Blue Ribbon Committee on Governance (BRC) reads:

1. To have an understanding of the hierarchy of CSHP governing documents:

a. Articles of Incorporationb. Bylaws c. House of Delegate (HOD) regulations d. Administrative policies

2. To review the following governing documents and identify issues or inconsistencies:

a. Articles of Incorporationb. Bylaws c. House of Delegate (HOD) regulationsd. Administrative policies

3. To revise, as necessary, CSHP governing documents

a. Align or crosswalk the HOD regulations and policies to the Bylawsb. Suggest revisions/additions of the HOD regulations, policies or Bylawsc. To ensure consistency and due process in CSHP businessd. To ensure checks and balances for professional and operational business and

accountability

4. Identify steps required to restore the reputation and level of trust at CSHP among stakeholders, i.e., CSHP members and affiliated organizations (CPTA, CSHP Foun-dation, etc.), legislators, and outside organizations. Identify short-term (1 year) and long-term goals (5 year).

Actions of the Committee1. The BRC completed its review of the Article of Incorporation, Bylaws, and House of

Delegates regulations in 2016. The work of this year’s committee was focused on the review and revision of the CSHP Administrative Policy manual.

2. The committee reviewed and recommended a complete reorganization of the Admin-istrative Policy manual. Such actions included:


Report of the CSHP Blue Ribbon Committee

a. Reorganization of the manual from a format by year to a format by topic.

b. Addition of clarifying language that provides guidance on what consti-tutes an administrative policy.

c. Added key words and phrases to make the manual more searchable.

d. Reviewed all 172 policies and recommended changes to 86 poli-cies and deletion of 27 policies.

e. Recommended CSHP Board review of all policies related to awards for streamlining and consistency.

f. Recommended a new system of a 5-year review based on topic rather than by year of last review.

g. Recommended a standard format for current and future policies to maintain consistency.

Conclusion• The BRC feels that charges 1 and 2

have been successfully completed.

• The recommendations above will lead to completion of charge 3, though the BRC recognizes that substantial work may be necessary by the BOD to review and modify the 86 policies recommended for amendment. The BOD may wish to consider whether this BRC or a new BRC should be organized to review the 86 up for review.

• The BRC recognizes that charge 4 does not provide objective outcomes and recommends an open discussion between the BOD and key stake-holders to verify whether the charge has been successfully completed. o

2017 CSHP Blue Ribbon Committee on GovernanceBill Yee, Chair Christine Antczak Elizabeth Chang Vicky Ferraresi Mylien Hong Kenn Horowitz Nancy Korman Patricia New Jay Rho Ken Schell Maria Serpa Jeff Suda Scott Takahashi

Documents

SPECIAL SUPPLEMENT ONLINE ISSUE of the CSHP House of ...€¦ · So, President-elect Daniel Dong, Treasurer Pauline Chan, and Maria Serpa who served as the parliamentarian for the